FDA Invites Comment on Drug Testing Guidance for Early AD
costs of AD by more than 50 percent.”—Esther Landhuis Submitted to The New York Times on 18 March 2013
ALL NEWS
373 RESULTS
You searched Landhuis
Sort By:
- Most Recent
- Most Commented
- Most Relevant
Law and Disorder—APPswe Patent Suits Raise Ruckus Again
is no reasonable time when I could predict it will be over.”—Esther Landhuis and Gabrielle Strobel. None
AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons
receptor antagonists.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1879 Alzheimer's
ADNI: One-year Data Narrow Field of MRI, FDG-PET Approaches
of the study,” she said.—Esther Landhuis. This is Part 1 of a two-part series. See also Part 2. None
Does ApoE4 Risk Begin in the Womb?
on motor skills, language, and memory development.—Esther Landhuis None
Brain Drain—“Glymphatic” Pathway Clears Aβ, Requires Water Channel
CSF flux and see if that slows plaque buildup.—Esther Landhuis None
Excess α-Synuclein Sends Synapses Sputtering
(Surmeier, 2010).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2473 Parkinson's
Does ApoE4 Lower Brain Metabolism Independently of Aβ?
on while they are thinking.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3348
Feedback Loop—Molecular Mechanism for PD, Gaucher’s Connection
patients.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2820 Parkinson's Disease Lipid
Perpetrator and Savior—Presenilins Cut Both Ways
2003).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2155 Alzheimer's Disease Aβ
CryoEM Exposes Possible Achilles’ Heel in Aβ1-42 Fibrils
online 13 February in the journal Biochemistry (Yu et al., 2009).—Esther Landhuis None
Complement: AD Friend or Foe? New Work Tips Balance to Former
neuronal loss, will be key to sorting out the role of inflammation in AD.—Esther Landhuis None
Medical Foods—Fallback Option for Elusive AD Drug Status?
twice—with news of elevated AD risk, and without another potential treatment option.—Esther Landhuis
Sirtuin Inhibitor Boosts Cognition, Reduces Phospho-tau
are safe.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1962 Alzheimer's Disease Sirtuins Tau
Abnormal Mitochondrial Dynamics—Early Event in AD, PD?
mitochondrial distribution abnormalities can lead to synaptic deficits in vivo.—Esther Landhuis None